[Heart transplantation. Indications, results and perspectives]. 1996

T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
Klinik für Herz-, Thorax- und Gefässchirurgie, Medizinische Hochschule Hannover.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075202 Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Contraindications, Physical Agent,Medical Contraindications,Agent Contraindication, Physical,Agent Contraindications, Physical,Contraindication,Contraindication, Medical,Contraindication, Physical Agent,Contraindications, Medical,Medical Contraindication,Physical Agent Contraindication,Physical Agent Contraindications
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
May 2000, Therapeutische Umschau. Revue therapeutique,
T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
January 1992, Zentralblatt fur Chirurgie,
T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
December 2007, Presse medicale (Paris, France : 1983),
T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
June 1990, Krankenpflege Journal,
T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
August 2004, Presse medicale (Paris, France : 1983),
T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
August 1990, Lakartidningen,
T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
May 1986, Der Internist,
T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
January 2001, Transplantation proceedings,
T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
May 1996, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
T Wahlers, and K Pethig, and H G Fieguth, and S Demertzis, and B Hausen, and A Mügge, and K Wolpers, and B Heublein, and H G Borst
January 1989, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
Copied contents to your clipboard!